In xenograft GBM mouse models injected with U87 or U251 cells, the treatment with carvacrol showed a significantly reduced tumor size in both mice, decreased expression of the p-Akt protein, and increased levels of GSK3β (312). This evidence concerns the gene AKT1 and neoplasm.